Obesity interacts with infectious mononucleosis in risk of multiple sclerosis

European Journal of Neurology

Volumn 22, Issue 3, 2015, Pages 578-e38

  Hedstrom A K ^a   Lima Bomfim, I ^a   Hillert, J ^b   Olsson, T ^b   Alfredsson, L ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Case control study; Demyelinating diseases; Epidemiology; Epstein Barr virus; Infectious mononucleosis; Multiple sclerosis; Obesity; Risk factors

Indexed keywords

HLA A ANTIGEN; HLA DRB1 ANTIGEN;

ADOLESCENT; ADOLESCENT DISEASE; ADOLESCENT OBESITY; ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CELLULAR IMMUNITY; CHILD; CHILDHOOD OBESITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC RISK; GENOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEOSIS; MULTIPLE SCLEROSIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SWEDISH CITIZEN; CASE CONTROL STUDY; COMPLICATION; INFECTIOUS MONONUCLEOSIS; INFLAMMATION; PEDIATRIC OBESITY; RISK; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; INFECTIOUS MONONUCLEOSIS; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; PEDIATRIC OBESITY; RISK; YOUNG ADULT;

EID: 84922626223     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12620     Document Type: Article

References (32)

1. Lincoln MR, Montpetit A, Cader MZ, et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005; 37: 1108-1112.
2. Brynedal B, Duvefelt K, Jonasdottir G, et al. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS One 2007; 2: e664.
3. IMSGC. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-219.
4. Hedström AK, Hillert J, Olsson T, Alfredsson L. Smoking and multiple sclerosis susceptibility. Eur J Epidemiol 2013; 28: 867-874.
5. Bäärnhielm M, Hedström AK, Kockum I, et al. Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15. Eur J Neurol 2012; 19: 955-962.
6. Ascherio A, Munger KL. Epstein-Barr virus and multiple sclerosis: a review. J Neuroimmune Pharmacol 2010; 5: 271-277.
7. Munger KL, Chitnis T, Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology 2009; 73: 1543-1550.
8. Hedström AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 2012; 18: 1334-1336.
9. Munger KL, Bentzen J, Laursen B, et al. Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler 2013; 19: 1323-1329.
10. Langer-Gould A, Brara SM, Beaber BE, Koebnic C. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology 2013; 80: 548-552.
11. Procaccini C, Carbone F, Galgani M, et al. Obesity and susceptibility to autoimmune diseases. Expert Rev Clin Immunol 2011; 7: 287-294.
12. Matarese G, Procaccini C, De Rosa V. The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis? J Leukoc Biol 2008; 84: 893-899.
13. Karlsson EA, Beck MA. The burden of obesity on infectious disease. Exp Biol Med 2010; 235: 1412-1424.
14. Hedström AK, Bomfim IL, Barcellos LF, et al. Interaction between adolescent obesity and HLA risk genes in the development of multiple sclerosis. Neurology 2014; 82: 865-872.
15. Sundqvist E, Sundström P, Lindén M, et al. Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun 2011; 13: 14-20.
16. Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000; 47: 831-835.
17. Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology, 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 2008.
18. Subramanian V, Ferrante AW. Obesity, inflammation, and macrophages. Nestle Nutr Workshop Ser Pediatr Program 2009; 63: 151-159.
19. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-1161.
20. reg dysfunction in multiple sclerosis. J. Immunol 2007; 179: 1322-1330.
21. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212: 8-27.
22. + regulatory T cells. Proc Natl Acad Sci USA 2005; 102: 5150-5155.
23. + regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971-979.
24. Carbone F, De Rosa V, Carrieri P, et al. Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat Med 2014; 20: 69-74.
25. Procaccini C, Galgani M, De Rosa V, Matarese G. Intracellular metabolic pathways control immune tolerance. Trends Immunol 2012; 33: 1-7.
26. De Rosa V, Procaccini C, Calì G, et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007; 26: 241-255.
27. Pender MP. CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis. Review. Autoimmune Dis 2012; 2012: 189096.
28. Chastain EM, Miller SD. Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease. Immunol Rev 2012; 245: 227-238.
29. Comans-Bitter WM, de Groof R, van den Beemd R, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997; 130: 388-393.
30. VanderWeele TJ. Sufficient cause interactions and statistical interactions. Epidemiology 2009; 20: 6-13.
31. Troy LM, Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Willett WC. The validity of recalled weight among younger women. Int J Obes Relat Metab Disord 1995; 19: 570-572.
32. Internet-based information. http://www.scb.se. (accessed 15/02/2013).